Replies to post #25151 on Grapefruit USA Inc (GPFT)

[tattooed]

Sano, you very well know that Dean could have sold out years ago but why would he? After approval is where the money is and you know that. You just spew your bs and it's stupid.

[Approved]

Sano, no big boy like GE or Toshiba will buyout IMGG without the DVIS being FDA approved. So there's no chance years ago I3 could have been bought out. Dean had to dump 107 million shares to keep I3 up and running and have some cash. Janes had no idea his stock was going to shoot up to $1.95 in November with no news.

[BuyOnDips]

Sano

You’re a business man; surely you can see how much added value the Dominion would have after FDA approval. I'm just guessing here but I would bet there has already been an offer made for the Dominion pre FDA approval? If so, it was not nearly what it would be worth afterwards. I think many companies can attest to what Hell the FDA is to get approval from especially these days. Imaging 3 is not the only one in this quagmire.

[Denunzio36]

Completely clueless. Where have you been for the past 3 years? Dean is holding because he knows the end game worth of this technology and product. You are grasping for any reason to be negative at this point. What will you say when this is approved?

[ElHefe]

Sano, I'll take one more wack at this although we've been through it many times. Your argument seems to be that IMGG is not a company that can spin up and start producing 500 machines a year. I totally agree. I've been to their facility, seen it, and it ain't happenin'. The thought process doesn't stop there however. As I've been pointing out, this is fundamentally an IP play. I have asked Mike before why, if this thing is so great, doesn't a Siemans, GE or Toshiba just plunk down $300 million right now and buy 'em. Mike's explanation has been that the major OEMs don't generally do their own R/D any more...they buy IP and bring it to market themselves; it's more cost effective for them to let others put the sweat and tears in and fail nine times out of ten. On the one in ten that works and has a market then they just buy 'em. It's a whole lot easier. Why not do so before FDA approval? Because they have a BOD and shareholders to explain themselves to and the surest way to cover one's ass over a transaction is to already have Federal certification completed. Does it cost them many multiples more to do it this way? Yes, but it's relative. What they, using their established market shares and economies of scale, can make on the product is many multiples again larger than either what they pay for it or what the IP company can make on it themselves if they try to go it alone.

This is Mike's explanation. One buys it or they don't but I will say that it conforms with generally observable data; I am unaware of purchases of BB companies with unapproved IP whereas it happens regularly with small companies that have passed through the FDA hoops. So, arguments over what IMGG can produce themselves are moot, only the misinformed here are under that impression. It comes down to how much credence one gives to the argument that Dean's IP is disruptive, scalable over a large market, and worth it not only to an OEM's bottom line but also to keeping out of their competitor's hands. On this point there can justifiably be difference of opinion and I have not seen the argument yet that can resolve this point with any degree of certainty. Calling it "doublespeak" is not an argument.

So therein lies the uncertainty with this company and to argue this point either way with certitude is just so much talk out of one's arse.

[hubris heyday]

Sano... Dean From 8/19/09 CC min 2:56
" we've right now started to see the construct development and see images from that. This is what I call stage 2, stage 3 is plug in to the prototype and then we got a stage 4 which is real time and then go and pull all the imagery that we want. So we should be at stage 4 probably by either the end of next week or it should be around the end of next week to the first week of September." Dean

"Please keep in mind this was one year ago." Hubris

Sano... Dean from 8/12/10 CC min 3:06

"I feel very confident with what we sent to the FDA that this is, should be enough. It should be enough to determine substantial equivalency. This with the Radiology review which obviously we wouldn't have sent if unless if it was you know in the informative of our product being substantially equivalent our image quality being as good as or if not better than you know the equipment that we compared our devices to in our application." Dean

"Please keep in mind someone put their reputation on the line and gave their word that the Dvis is SE!" Hubris

Sano, it's a slow process BUT Dean can get funding all day long for this tech! Your thoughts and questions are about as good as a chart! No one tells me to put large buy orders in but me. Breakaway's product sucks!

Big question is will the FDA find SE?????????????
Try CC min 1:14. 1/12/10 Dean talks about the FDA's trouble with this. I say flip a coin all PPS aside.
As ImggBust would say... Stay thirsty my friends! LMAO P.S good pick I B